Thermal Pulsation Versus Warm Compress Treatment for Meibomian Gland Dysfunction
Completed · Phase 4
Conditions studied: Meibomian Gland Dysfunction
In brief
This study aimed to assess the treatment outcome differences between a single, in-office bilateral treatment with the thermal pulsation system and twice-daily, 10-minute applications of the warm compress mask at home for 8 weeks.
Key facts
- Study ID
- NCT06326931
- Run by
- Jacksoneye
- People needed
- 68
- Starts
- 2022-06-24
- Expected to finish
- 2023-06-22
- Last updated by the study team
- 2024-03-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- history of self-reported dry eye symptoms for 3 months prior to study enrollment
- baseline OSDI score of 23 or greater (
- MGS score of 12 ior less in the lower eyelid of each eye
- TBUT <10 seconds
- willing and able to abstain from using any new ocular lubricants
You may not qualify if…
- diagnosis of thyroid dysfunction or rheumatoid arthritis
- history of laser-assisted in situ keratomileusis (LASIK); any other ocular surgery within the previous 12 months
- abnormal lid anatomy or active lid lesions
- use of topical glaucoma medications, medications affecting the central nervous system, or hormonal drugs within the previous month
- active ocular infection
- pterygium
- planned use of contact lenses, topical antibiotics, steroids, or immunomodulating drops
- CDVA worse than 0.2 logMAR
Where it is running
- Jacksoneye — Lake Villa, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.